Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2047859 | FEBS Letters | 2012 | 6 Pages |
The cytokines interleukin (IL)-1β and tumor necrosis factor (TNF)-α induce β-cell death in type 1 diabetes via NF-κB activation. IL-1β induces a more marked NF-κB activation than TNF-α, with higher expression of genes involved in β-cell dysfunction and death. We show here a differential usage of the IKK complex by IL-1β and TNF-α in β-cells. While TNF-α uses IKK complexes containing both IKKα and IKKβ, IL-1β induces complexes with IKKα only; this effect is achieved by induction of IKKβ degradation via the proteasome. Both IKKγ and activation of the TRAF6-TAK1-JNK pathway are involved in IL-1β-induced IKKβ degradation.
► Differential usage of IKK complex components by IL-1β and TNF-α in beta cells. ► The IKK complex induced by IL-1β in beta cells lacks the IKKβ subunit. ► IL-1β, but not TNF-α, induces degradation of IKKβ in pancreatic beta cells. ► IL-1β-induced IKKβ degradation is dependent on proteasome activity and IKKγ. ► IL-1β-induced IKKβ degradation depends on TRAF6-TAK1-JNK activation.